B

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Medical Director - Clinical Development

Biology & BiotechUpdated on Nov 10
Full-timeCambridge, MA, USA$266k - $340k

About the Job

Requirements

  • An MD or DO, or MD/PhD, is required.
  • At least 5 years of combined clinical and pharmaceutical or biotechnology industry experience is required.
  • Direct experience treating or managing lupus (SLE and/or CLE) and/or systemic sclerosis patients or clinical programs is strongly preferred.
  • Deep scientific expertise in autoimmune disease, particularly rheumatology, lupus (SLE and/or CLE), or systemic sclerosis, is preferred.
  • Direct experience with Phase 1–3 clinical studies, including authoring clinical trial protocols, clinical development plans, and regulatory submission documents, is required.
  • Deep clinical and scientific expertise in immunology and inflammation, including disease mechanisms, clinical trial landscapes, standard-of-care evolution, regulatory developments, and emerging therapeutic approaches, is required.
  • Ability to identify, characterize, and mitigate clinical, operational, and regulatory risks across multisite, multinational clinical programs is required.
  • Ability to lead and influence cross-functional teams in a matrixed, fast-paced biotechnology or pharmaceutical environment without direct line authority is required.
  • Ability to build alignment across internal and external stakeholders, including senior leadership, clinical operations, regulatory, and commercial partners, is required.
  • A track record of driving program-level decisions with clarity and accountability while balancing scientific rigor with business urgency in resource-constrained settings is required.
  • Scientific communication skills to explain complex medical and clinical data to senior leadership, health authorities, clinical investigators, and external partners are required.
  • Scientific writing proficiency, including evaluating and presenting complex data sets in regulatory documents, clinical study reports, and scientific publications, is required.
  • Ability to facilitate high-stakes discussions, including advisory boards, cross-functional program reviews, and health authority interactions, is required.
  • Board certification or clinical training in rheumatology, nephrology, immunology, or a related specialty is strongly preferred.
  • An additional advanced degree such as a PhD, MPH, or MBA is a plus.

Responsibilities

  • Lead and provide medical oversight for assigned clinical trials, including protocol development, study conduct, medical monitoring, data review and interpretation, and clinical study reporting.
  • Contribute to clinical development strategy and program plans by integrating scientific rationale, regulatory requirements, safety considerations, operational feasibility, and business objectives.
  • Provide medical leadership on trial design, including endpoint selection, eligibility criteria, dose rationale, biomarker strategy, risk-based monitoring, and interim analysis frameworks.
  • Monitor real-time data collection throughout study conduct to ensure robust study conduct and protocol adherence.
  • Support pharmacovigilance activities during trial conduct by monitoring patient safety and benefit-risk through review of adverse events, serious adverse events, laboratory data, safety narratives, and aggregate safety information, and contribute to related safety governance activities in coordination with the Global PV Medical Director.
  • Serve as a key medical resource for investigative sites, external advisors, and clinical investigators by ensuring patients meet appropriate eligibility criteria, responding to clinical and safety inquiries, and supporting external interactions, advisory boards, and scientific communications as appropriate.
  • Lead and conduct peer-to-peer scientific exchange with KMEs, investigators, and HCPs by sharing clinical and emerging data, discussing unmet medical needs, and gathering external insights that inform development strategy.
  • Review, author, and contribute to clinical and regulatory documents, including protocols, protocol amendments, investigator brochures, informed consent forms, clinical study reports, briefing materials, and health authority responses.
  • Support regulatory interactions and submissions by providing medical and scientific input for agency meetings, annual reports, and clinical sections of regulatory filings.
  • Serve as the clinical development lead for an asset if required.
  • Perform other duties and responsibilities as assigned.

Desired Qualifications

  • Board certification or clinical training in rheumatology, nephrology, immunology, or a related specialty.
  • Direct experience treating or managing lupus (SLE and/or CLE) and/or systemic sclerosis patients or clinical programs.
  • Deep scientific expertise in autoimmune disease, particularly rheumatology, lupus (SLE and/or CLE), or systemic sclerosis.
  • An additional advanced degree such as a PhD, MPH, or MBA.

About the Company

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Beeline Medicines focuses on precision therapies for autoimmune and inflammatory diseases, advancing a portfolio of in-licensed programs from Bristol Myers Squibb with strong backing from Bain Capital. Its lead, afimetoran, is an oral TLR7/8 inhibitor for lupus, with lomedeucitinib as an allosteric TYK2 inhibitor and two IND-stage biologics targeting IL-18 and IL-10 pathways to modulate immune signaling. The company differentiates itself by combining externally sourced programs with a leadership team experienced in drug development and commercialization, pursuing multiple mechanism-driven candidates rather than a single modality, supported by substantial early funding. Its goal is to move its clinical-stage therapies toward pivotal trials and bring targeted immune-modulating treatments to patients, beginning with completing Phase 2 for afimetoran in late 2026 and following with a pivotal program.

Company size
51-200
Company stage
Series A
Total funding
$426.3M
Headquarters
Stamford, CT
Founded
2025

Recently Posted Jobs

Explore more opportunities at Beeline Medicines

See more jobs